Genstruct, Inc. Appoints Michael R. Pavia to Board of Directors

Strategic Insights -

Genstruct, a systems biology company, has added a prominent figure to its board of directors. Michael R. Pavia, a highly experienced executive in the pharmaceutical industry, has joined the company's board with a strong track record in developing and integrating new technologies into the drug-discovery and -development process. Pavia's expertise is expected to play a crucial role in growing Genstruct's relationships with major pharmaceutical companies, such as Pfizer and Berlex, leveraging his past experience as the CTO of Millennium Pharmaceuticals. As an entrepreneur-in-residence with Oxford Biosciences Partners, Pavia brings valuable insights to Genstruct, which is focused on complex diseases in oncology, metabolic disorders, and inflammation.

Key Takeaways:

  • Michael R. Pavia, former CTO of Millennium Pharmaceuticals, has been appointed to Genstruct's board of directors, bringing over 20 years of pharmaceutical research and discovery experience.
  • Pavia's expertise in integrating new technologies into drug-discovery and -development processes is expected to grow Genstruct's relationships with pharmaceutical companies like Pfizer and Berlex.
  • As an entrepreneur-in-residence with Oxford Biosciences Partners, Pavia will contribute to Genstruct's growth using his expertise in bringing new technology to pharmaceutical companies.
  • Genstruct is a systems biology company focused on understanding and treating complex diseases in oncology, metabolic disorders, and inflammation.
  • The company, founded in 2002, aims to leverage new approaches to tackle these complex diseases.

Statistics:

  • 20 years of experience in pharmaceutical research and discovery for Michael R. Pavia.
  • Genstruct was founded in 2002.
  • The company is focused on complex diseases in oncology, metabolic disorders, and inflammation.

Sources:

  • Health & Medicine Week
  • NewsRx.com
  • Oxford Biosciences Partners
  • Millennium Pharmaceuticals was founded, although no date is mentioned in the article, according to company history.